Medical Innovation And Research companies

Building next generation companies to enhance healthy lifespan.

Crafted capital to fuel life science breakthroughs.

The Michigan Biomedical Venture Fund (MBVF) invests in and supports life science startup companies with U-M licensed intellectual property – including therapeut…

We invest in cancer innovation, together.

At SGInnovate, we launch, prove & scale deep tech products borne out of science research.

Identifying true innovations and building ambitious companies.

Accelerating life-extending therapies, treatments and cures for all myeloma patients.

We unite research, venture building, programs, and investments to make healthcare more affordable, accessible, and impactful.

RightHill Ventures provides venture capital and other support to early-stage technology companies commercializing the most promising R&D coming from universitie…

Atlas Venture invests in early-stage life sciences innovation. We partner with remarkable entrepreneurs to build breakthrough biotech companies.

Invested in breaking ‍through paralysis.

We are long-term investors in engineering biology to treat - or better, cure - human disease.

We build and invest in companies that transform healthcare.

At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation.

We help bright ideas become businesses and nurture a 21st century economy.

We invest in therapeutic medical devices, diagnostics, and digital health. Our focus is innovative technologies that significantly improve patient outcomes and…

We're biomedical researchers investing in a new generation of translational founders.

Innovation Works helps software, hardware, and life sciences startups throughout Southwestern Pennsylvania get to their next stage of growth.

We are a Super Incubator helping medtech startups build, test, and market innovations with the ultimate goal of successful exits or commercialisation.​